SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-21-033810
Filing Date
2021-06-23
Accepted
2021-06-23 17:11:43
Documents
1
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1526
  Complete submission text file 0001213900-21-033810.txt   2943
Mailing Address 2569 WYANDOTTE, ST. SUITE 101 MOUNTAIN CA 94043
Business Address 2569 WYANDOTTE, ST. SUITE 101 MOUNTAIN CA 94043 909-488-0844
Aditx Therapeutics, Inc. (Issuer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1620 BEACON STREET OXNARD CA 93033
Business Address
Chung Lauren (Reporting) CIK: 0001847773 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39336 | Film No.: 211039427